DIFFUSIONS-ALPHA-EMITTER-STRAHLENTHERAPIE MIT VERBESSERTER BETA-BEHANDLUNG

European patent · EP4262888 · In force

Register entry

Publication number
EP4262888
Application number
EP21905935
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 14, 2021
Published
Oct 25, 2023
Granted
Feb 4, 2026
Protection ends at the latest
Dec 13, 2041
Next annual fee due
Dec 31, 2026
IPC classes
A61N 5/10 (2006.01)
A61M 37/00 (2006.01)
A61K 51/12 (2006.01)
A61K 9/00 (2006.01)
A61K 51/02 (2006.01)
A61L 31/10 (2006.01)
Priority
US 202063126070 P 16.12.2020
PCT application
PCT/IB2021/061687 14.12.2021
PCT publication
WO2022/130195 23.06.2022
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 19, 2026

    Agent entered

    Representative
    Dennemeyer AG, Bahnhofstrasse 23, 6300 Zug

    Published in Swissreg on 19.02.2026

  2. Feb 4, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 04.02.2026

Parties

Holder

Alpha TAU Medical Ltd.

Alpha Tau Medical Ltd.

5 Kiryat Hamada Street, 9777605 Jerusalem, IL

Agent

Dennemeyer AG

Bahnhofstrasse 23, 6300 Zug

Inventor

ARAZI, Lior

6998401 Tel Aviv, IL

DEN, Robert B

Merion Station, Pennsylvania 19066, US

SCHMIDT, Michael

4453507 Kfar Saba, IL

MAGEN, Ofer

4541509 Hod Hasharon, IL

KELSON, Itzhak

6439606 Tel Aviv, IL

GAT, Amnon

4585800 Matan, IL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.